Esophageal cancer (EC) is one of the most common types of cancer worldwide and was ranked as the sixth leading cause of cancer-related deaths in 2020. When EC is localized or locally advanced, referred to as resectable EC, ...
Feb 1, 2023
0
7
Radiotherapy, which uses high-energy radiation to kill cancer cells, typically follows a dosing and treatment plan based on clinical research to minimize the impact of the radiation on healthy tissues. However, since the ...
Jan 31, 2023
0
90
A type of cell that plays a key role in pancreatic cancer can trace its origin back to a structure that forms during embryonic development, new research at MUSC Hollings Cancer Center shows. This new data, published recently ...
Jan 20, 2023
0
68
Our immune systems react most strongly to the viral strains we encountered in our childhoods. Scientists call this original antigenic sin (OAS)—the body's first blush with a virus like influenza or COVID being the "original ...
Jan 18, 2023
0
49
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks.
Jan 17, 2023
0
64
While an impending storm will trigger cautionary news reports about the risk of a heart attack while shoveling snow, you're less likely to hear how twisting and turning while moving heavy amounts of the tiny ice crystals ...
Jan 16, 2023
0
2
In the past decade, researchers have begun to appreciate the importance of a two-way communication that occurs between microbes in the gastrointestinal tract and the brain, known as the gut–brain axis. These "conversations" ...
Jan 13, 2023
0
1084
Monitoring the proper blood supply to the brain is crucial, not only to prevent neurological diseases, but also to treat them. The parallel near-infrared interferometric spectroscopy technique, or simply πNIRS, could make ...
Jan 9, 2023
0
33
MUSC Hollings Cancer Center oncologists found that using a combination monoclonal antibody (tixagevimab-cilgavimab) against the SARS-CoV-2 spike protein in patients with blood cancers prevented moderate and severe COVID cases. ...
Dec 16, 2022
0
18
Treating people for long COVID—that is, symptoms that last longer than four weeks after COVID infection—can be extremely complex due to the wide variety of problems associated with the condition.
Dec 8, 2022
0
8
